Veritas Collagen Matrix Cystocele Repair Study - Postmarketing
NCT ID: NCT00860912
Last Updated: 2017-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
94 participants
INTERVENTIONAL
2001-12-31
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes of Anterior Colporrhaphy Versus Graft Reinforced Anterior Prolapse Repair
NCT00535301
Composite Outcomes of Mesh vs Suture Techniques for Prolapse Repair: A Randomized Controlled Multicentre Trial
NCT02965313
A Study Of Cryptoglandular Fistula-in-ano And Associated Non-healing Draining Wounds With Kerecis SurgiClose
NCT07098715
Surgical Repair of Vaginal Wall Prolapse Using Gamma Irradiated Amniotic Membrane as a Scaffold
NCT05355623
REDUCE Trial- Reducing Prolapse Recurrence
NCT04880239
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention: Collagen matrix
Cystocele repair: Veritas reinforcing material implanted for reinforcement of cystocele repair with collagen matrix
Collagen Matrix
surgical/reinforcing material
Native tissue repair
Intervention: Cystocele repair performed: No reinforcing material used and routine performance of a cystocele repair using native tissues.
Collagen Matrix
surgical/reinforcing material
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Collagen Matrix
surgical/reinforcing material
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female
* Meets follow-up evaluation time frame
* Understands the nature of the procedure and has provided written informed consent
* Is scheduled to undergo vaginal pelvic reconstructive surgery
* Has \> 2nd degree midline cystocele
Exclusion Criteria
* Previous pelvic organ prolapse surgery using an implant that will affect the use of the VCM or affect the outcome of the study
* Allergy to bovine material
* Severe mucosal atrophy
* Shortened vaginal length as determined by Investigator
* Pregnant or intends to become pregnant during study
* Has a UTI
* Has vault prolapse \< 2nd degree cystocele
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillermo W Davila, MD
Role: PRINCIPAL_INVESTIGATOR
Cleveland Clinic Florida
References
Explore related publications, articles, or registry entries linked to this study.
Guerette NL, Peterson TV, Aguirre OA, VanDrie DM, Biller DH, Davila GW. Anterior repair with or without collagen matrix reinforcement: a randomized controlled trial. Obstet Gynecol. 2009 Jul;114(1):59-65. doi: 10.1097/AOG.0b013e3181a81b41.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB# 85852010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.